Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-17

FDA Approved: VIGAFYDE — Original Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approves VIGAFYDE (vigabatrin) from Upsher-Smith in an original NDA; the product is indicated for certain seizure disorders, including infantile spasms and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • VIGAFYDE (VIGABATRIN)

Snippet

ORIG AP for VIGAFYDE (VIGABATRIN)